| Page 1437 | Kisaco Research

Integrating the Mythic Analog Matrix Processor into AI Edge Platforms

Time-to-market is a critical aspect of bringing an Edge AI product to market.  When selecting an AI processor, it is important for the evaluation and integration process to be as seamless and as simple as possible.  In this webinar we will show how easy it is to integrate the Mythic Analog Matrix Processor (AMP) into popular hardware platforms including Intel X86, NVIDIA and Qualcomm for accelerating AI at low power.  We will provide a brief overview of the Mythic AMP and the hardware requirements for integration.

 

C.H. Chee

Senior Director of Business Development and Marketing
Mythic

C.H. Chee

Senior Director of Business Development and Marketing
Mythic

C.H. Chee

Senior Director of Business Development and Marketing
Mythic
 

Jimmy Chiu

Director of AI Solutions
Mythic

Jimmy Chiu

Director of AI Solutions
Mythic

Jimmy Chiu

Director of AI Solutions
Mythic
 

Henrik Bjørn Nielsen

CSO
Clinical Microbiomics

Henrik Bjørn Nielsen

CSO
Clinical Microbiomics

Henrik Bjørn Nielsen

CSO
Clinical Microbiomics
 

Ruth Luna Ann

Assistant Professor
Baylor College of Medicine

Ruth Luna Ann

Assistant Professor
Baylor College of Medicine

Ruth Luna Ann

Assistant Professor
Baylor College of Medicine
 

Romaine Daillere

Co-Founder & Head of Preclinical Research
Everimmune

Romain Daillère completed his PhD in 2015 in the laboratory of Professor Laurence Zitvogel at the Gustave Roussy Cancer Campus (GRCC), Villejuif-Grand Paris/France. His research focuses on the complex interplay between gut microbiota and the efficacy of anticancer regimens. He previously graduated as a biotechnology engineer at the Ecole Supérieure de Biotechnology de Strasbourg (Trinational School of Strasbourg), and worked at the Ragon Institute of MIT, MGH and Harvard in Boston. Co-founder of EverImmune. Co-Inventor of EverImmune Technology.

Romaine Daillere

Co-Founder & Head of Preclinical Research
Everimmune

Romaine Daillere

Co-Founder & Head of Preclinical Research
Everimmune

Romain Daillère completed his PhD in 2015 in the laboratory of Professor Laurence Zitvogel at the Gustave Roussy Cancer Campus (GRCC), Villejuif-Grand Paris/France. His research focuses on the complex interplay between gut microbiota and the efficacy of anticancer regimens. He previously graduated as a biotechnology engineer at the Ecole Supérieure de Biotechnology de Strasbourg (Trinational School of Strasbourg), and worked at the Ragon Institute of MIT, MGH and Harvard in Boston. Co-founder of EverImmune. Co-Inventor of EverImmune Technology. He currently acts as head of the preclinical research of EverImmune.

 

Rochellys Diaz Heijtz

Associate Professor
Karolinska Institute

Rochellys Diaz Heijtz

Associate Professor
Karolinska Institute

Rochellys Diaz Heijtz

Associate Professor
Karolinska Institute
 

John Weinberg

Chief Medical Officer
MaaT Pharma

John Weinberg

Chief Medical Officer
MaaT Pharma

John Weinberg

Chief Medical Officer
MaaT Pharma
 

Denise Kelly

Consultant
Seventure

Denise Kelly

Consultant
Seventure

Denise Kelly

Consultant
Seventure
 

Anita Patel Jusnes

Chief Commercial Officer
Genetic Analysis

Anita Patel Jusnes

Chief Commercial Officer
Genetic Analysis

Anita Patel Jusnes

Chief Commercial Officer
Genetic Analysis